In our prior studies, we found that the expression of SPRED1 was significantly reduced, which was closely related to the hypermethylation of SPRED1 in non-APL patients, and the patients who obtained CR might be with decreasing methylation level of SPRED1 (14). This evidence concerns the gene SPRED1 and acute promyelocytic leukemia.